Atrial fibrillation in the Americas

Jason G Andrade1,2, Larry R Jackson3, Juan Carlos Diaz4

  • 1Center for Cardiovascular Innovation, Vancouver General Hospital, Vancouver, Canada.

Insights

Atrial Fibrillation (AF) management varies significantly across the Americas due to regional disparities in healthcare access and resources. Addressing these health inequities is crucial to improve care and reduce the economic burden of AF.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Atrial Fibrillation (AF) is the most prevalent sustained cardiac arrhythmia, significantly impacting patient quality of life.
  • Substantial regional variations exist in AF incidence, prevalence, and consequences (e.g., disability-adjusted life years, mortality) across the Americas.
  • Contemporary AF management goals are consistent, yet implementation differs widely due to access, diagnostic, and treatment variations.

Purpose of the Study:

  • To highlight the regional disparities in Atrial Fibrillation management across the Americas.
  • To identify key drivers of variability in AF care, including healthcare access, diagnostics, treatments, and economic factors.
  • To emphasize the need for targeted healthcare policies to mitigate inequities and reduce the burden of AF.

Main Methods:

  • This study synthesizes existing data on Atrial Fibrillation prevalence, incidence, and management across the Americas.
  • Analysis focuses on identifying regional differences in healthcare resource allocation, technological adoption, and treatment accessibility.
  • A review of health policies and economic factors influencing AF care delivery is conducted.

Main Results:

  • Significant regional variations in Atrial Fibrillation incidence, prevalence, and associated mortality/morbidity are observed throughout the Americas.
  • Management strategies for AF are highly variable, influenced by country-specific healthcare expenditures and access to advanced medical services and technologies.
  • Disparities in access to diagnostics and treatments contribute to inconsistent AF care across different regions.

Conclusions:

  • Addressing within- and between-country healthcare barriers is essential for improving Atrial Fibrillation care and reducing its economic impact.
  • Failure to resolve health inequities in AF management will likely increase the strain on healthcare resources.
  • Implementing tailored healthcare policies can lead to more equitable and effective Atrial Fibrillation treatment across the Americas.